1. Home
  2. Category
  3. Treatment Types

Stem Cell Transplant

Article

Frailty in Patients With Hematologic Malignancies and Those Undergoing Transplantation: A Scoping Review

Lathika Mohanraj
Lana Sargent
Roy Brown
Theresa Swift-Scanlan
ONF 2021, 48(3), 291-307 DOI: 10.1188/21.ONF.291-307
Problem Identification: Although frailty is an important parameter in treatment planning and in predicting prognosis and overall survival among patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation, frailty assessment tools are not standardized in clinical...
0
No votes yet
Read this Article
Article

Hypoglycemia: Comparison of Health Status Outcomes Between Patients After Allogeneic Hematopoietic Cell Transplantation

Cara Malone
Michelle A. Mathiason
Elaine Stenstrup
Mary Fran Tracy
CJON 2021, 25(2), 161-168 DOI: 10.1188/21.CJON.161-168
Background: Patients who have undergone hematopoietic cell transplantation (HCT) often face lengthy hospital stays. Hospitalized patients’ compromised health status puts them at risk for complications to recovery when glucose is not controlled. Objectives: This study aimed to investigate...
0
No votes yet
Read this Article
Online Exclusive Article

Transplantation and Adherence: Evaluating Tacrolimus Usage in Pediatric Patients With Cancer

Micah A. Skeens
Mary S. Dietrich
Nancy Ryan-Wenger
Mary Jo Gilmer
Shelagh A. Mulvaney
Terrah Foster Akard
CJON 2020, 24(5), E57-E64 DOI: 10.1188/20.CJON.E57-E64
Background: Researchers have estimated that about 50% of pediatric patients with chronic illness adhere to tacrolimus therapy, a medication responsible for preventing critical side effects in patients undergoing hematopoietic stem cell transplantation (HSCT). Objectives: The purpose of this study...
0
No votes yet
Read this Article
Online Exclusive Article

NEWS Scoring System: Use in Hematologic Malignancies and Cellular Therapeutics Patient Populations

Kelsey Suhr
Cyndy Steen
Robin Albrecht-Thompson
Jennifer Williams
CJON 2020, 24(2), E21-E27 DOI: 10.1188/20.CJON.E21-E27
Background: Systemic inflammatory response syndrome (SIRS) criteria can be overly sensitive in detecting clinical deterioration in hematologic malignancies and cellular therapeutics (HMCT) populations. This may create inconsistency in activation of a rapid response team (RRT) with patient decline...
0
No votes yet
Read this Article
NCPD Article

Central Line Care: Reducing Central Line–Associated Bloodstream Infections on a Hematologic Malignancy and Stem Cell Transplant Unit

Josephine Beaudry
Kathleen ScottoDiMaso
CJON 2020, 24(2), 148-152 DOI: 10.1188/20.CJON.148-152
Background: Patients with hematologic malignancies and stem cell transplant recipients are at increased risk for infections because of their prolonged periods of profound neutropenia. Central line–associated bloodstream infections (CLABSIs) can result in lengthy hospitalizations, increased...
5
Average: 5 (3 votes)
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.